What is Performant Healthcare, Inc.'s earnings per share (EPS)?

Performant Healthcare, Inc. (PHLT) reported diluted earnings per share of -$0.13 for fiscal year 2024. This represents a -30.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Performant Healthcare, Inc. (PHLT) Financials

PHLT

Trailing 12 months to June 30, 2025

Revenue $137.4M +15.2% YoY

Net Income -$885K +86.0% YoY

EPS (Diluted) -$0.01 +87.5% YoY

Free Cash Flow -$441K -3292.3% YoY

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2025, ended Jun 30, 2025 Reported Aug 7, 2025 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2025, filed Aug 7, 2025. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the PHLT SEC filings page.

Performant Healthcare, Inc. (PHLT) reported $137.4M in revenue over the twelve months to Jun 30, 2025, up 15.2% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI PHLT FY2024 2026-10-03

Revenue has recovered, but persistent losses and reinvestment still prevent the business from producing free cash flow.

In FY2024, operating cash flow reached $6.2M while the company posted a net loss of $9.9M, so reported losses exceeded the cash consumed by day-to-day operations. Yet capital intensity changed that picture: $7.0M of capital spending exceeded cash generated, leaving free cash flow at -$832K.

Revenue moved from $109.2M in FY2022 to $123.0M in FY2024, yet the operating margin remained negative, showing recovery in activity without recovery in operating economics. The margin worsened from -6.3% to -7.7%, indicating costs were still absorbing the improvement rather than fixed costs being spread more efficiently.

Debt-to-equity fell from 2.0x in FY2020 to 0.3x in FY2024, indicating a much less debt-dependent balance sheet. Shares outstanding rose from 76.9M in FY2023 to 78.3M in FY2024, adding dilution while losses continued.

Financial Health Signals

Financial Health Score 56/100

Scored as: Emerging companies peer group

Scored against emerging companies for FY2024. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Performant Healthcare, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway

Performant Healthcare, Inc. held $9.3M in cash, cash equivalents and investments at the end of fiscal year 2024, and its operations generated $6.2M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Performant Healthcare, Inc. scores 86/100 among other emerging companies.

Dilution

Performant Healthcare, Inc. had 78M shares outstanding at the end of fiscal year 2024, against 77M in fiscal year 2023. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and Performant Healthcare, Inc. scores 65/100 among other emerging companies.

R&D Intensity

Not available for Performant Healthcare, Inc., and counted as zero in the overall score.

Revenue Progress

Performant Healthcare, Inc. reported revenue of $123.0M in fiscal year 2024, against $113.7M in fiscal year 2023. Revenue Progress ranks emerging companies on the three-year path of that line, and Performant Healthcare, Inc. scores 51/100 among other emerging companies.

Burn Trend

Performant Healthcare, Inc.'s operations generated $6.2M of cash in fiscal year 2024, against $3.9M generated in fiscal year 2023. Burn Trend ranks emerging companies on which way that figure has moved over three years, and Performant Healthcare, Inc. scores 97/100 among other emerging companies.

Balance Sheet

Performant Healthcare, Inc.'s cash, cash equivalents and investments came to $9.3M at the end of fiscal year 2024, against $25.3M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Performant Healthcare, Inc. scores 37/100 among other emerging companies.

Altman Z-Score Safe

14.69

Performant Healthcare, Inc. scores 14.69, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($612.2M) relative to total liabilities ($25.3M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

3/7

Performant Healthcare, Inc. passes 3 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality Mixed

N/A

Performant Healthcare, Inc. reported a net loss of $9.9M while generating $6.2M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

Performant Healthcare, Inc. reported an operating loss of $9.5M against $700K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$37.8M

YoY+28.7%

QoQ+13.6%

5Y CAGR+2.3%

10Y CAGR-0.9%

Performant Healthcare, Inc. generated $37.8M in revenue in Q2 2025. This represents an increase of 28.7% from the same quarter a year earlier. Against the prior quarter it is up 13.6%.

EBITDA

$4.1M

YoY+592.3%

QoQ+158.4%

10Y CAGR-3.5%

Performant Healthcare, Inc.'s EBITDA was $4.1M in Q2 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 592.3% from the same quarter a year earlier. Against the prior quarter it is up 158.4%.

Net Income

$2.1M

YoY+169.4%

QoQ+2665.4%

10Y CAGR+11.1%

Performant Healthcare, Inc. reported $2.1M in net income in Q2 2025. This represents an increase of 169.4% from the same quarter a year earlier. Against the prior quarter it is up 2665.4%.

EPS (Diluted)

$0.03

YoY+175.0%

10Y CAGR+11.6%

Performant Healthcare, Inc. earned $0.03 per diluted share (EPS) in Q2 2025. This represents an increase of 175.0% from the same quarter a year earlier.

Cash & Balance Sheet

Free Cash Flow

-$867K

YoY-123.3%

QoQ-159.6%

Performant Healthcare, Inc. recorded an outflow of $867K in free cash flow in Q2 2025, representing a cash shortfall after capex. This represents a decrease of 123.3% from the same quarter a year earlier. Against the prior quarter it is down 159.6%.

Cash & Debt

$9.1M

YoY-12.9%

QoQ-9.1%

5Y CAGR-9.8%

10Y CAGR-19.2%

Performant Healthcare, Inc. held $9.1M in cash as of Q2 2025; long-term debt is not reported for that period.

Shares Outstanding

79M

YoY+2.3%

QoQ+0.9%

5Y CAGR+7.6%

10Y CAGR+4.8%

Performant Healthcare, Inc. had 79M shares outstanding in Q2 2025. This represents an increase of 2.3% from the same quarter a year earlier. Against the prior quarter it is up 0.9%.

Dividends Per Share

Not reported for Q2 2025.

Margins & Returns

Operating Margin

7.0%

YoY+16.3pp

QoQ+6.5pp

5Y change+23.0pp

10Y change-1.8pp

Performant Healthcare, Inc.'s operating margin was 7.0% in Q2 2025, reflecting core business profitability. This is up 16.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 6.5 percentage points.

Net Margin

5.5%

YoY+15.7pp

QoQ+5.7pp

5Y change+26.8pp

10Y change+3.7pp

Performant Healthcare, Inc.'s net profit margin was 5.5% in Q2 2025, showing the share of revenue converted to profit. This is up 15.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 5.7 percentage points.

Return on Equity

2.5%

YoY+6.5pp

QoQ+2.6pp

5Y change+23.1pp

10Y change+1.7pp

Performant Healthcare, Inc.'s ROE was 2.5% in Q2 2025, measuring profit generated per dollar of shareholder equity. This is up 6.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.6 percentage points.

Gross Margin

Not reported for Q2 2025.

Capital Allocation

Capital Expenditures

$1.3M

YoY+51.2%

QoQ-10.6%

5Y CAGR+8.3%

10Y CAGR-3.8%

Performant Healthcare, Inc. invested $1.3M in capex in Q2 2025, funding long-term assets and infrastructure. This represents an increase of 51.2% from the same quarter a year earlier. Against the prior quarter it is down 10.6%.

R&D Spending

Not reported for Q2 2025.

Share Buybacks

Not reported for Q2 2025.

PHLT Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PHLT quarterly income statement

Metric	TTM	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K	FY1010-K
Revenue	$137.4M	$123.0M+8.1%	$113.7M+4.2%	$109.2M-12.2%	$124.4M-20.2%	$155.9M+3.7%	$150.4M-3.4%	$155.7M+17.9%	$132.0M-6.6%	$141.4M-11.3%	$159.4M-18.4%	$195.4M-23.5%	$255.3M+21.5%	$210.1M+28.9%	$163.0M+31.9%	$123.5M
SG&A Expenses	$104.9M	$100.4M+11.0%	$90.4M+6.0%	$85.3M-2.4%	$87.4M-13.1%	$100.7M-12.6%	$115.2M+19.8%	$96.1M+17.0%	$82.2M+4.2%	$78.9M-10.5%	$88.1M-6.0%	$93.7M-3.2%	$96.8M+16.6%	$83.0M+23.7%	$67.1M+15.4%	$58.1M
Operating Income	-$48K	-$9.5M-55.0%	-$6.1M+11.2%	-$6.9M-424.3%	-$1.3M+90.6%	-$14.0M+28.9%	-$19.6M-993.4%	-$1.8M+74.6%	-$7.1M+10.6%	-$7.9M-218.2%	$6.7M-75.4%	$27.3M-62.6%	$72.9M+30.7%	$55.8M+67.5%	$33.3M+4.9%	$31.8M
EBITDA	N/A	-$2.9M-208.4%	-$941K+60.4%	-$2.4M-161.4%	$3.9M+144.3%	-$8.7M+21.3%	-$11.1M-231.7%	$8.4M+121.9%	$3.8M-30.3%	$5.5M-72.5%	$19.8M-50.0%	$39.7M-52.4%	$83.5M+28.0%	$65.3M+59.0%	$41.1M+5.4%	$39.0M
Interest Expense	$779K	$700K-64.5%	$2.0M+96.0%	$1.0M-91.1%	$11.3M+56.5%	$7.2M-4.8%	$7.6M+61.5%	$4.7M-32.6%	$7.0M-11.7%	$7.9M-11.2%	$8.9M-12.6%	$10.2M-12.0%	$11.6M-6.8%	$12.4M-8.2%	$13.5M-11.2%	$15.2M
Income Tax	$17K	-$351K-3.2%	-$340K-357.6%	$132K+112.9%	$62K+100.9%	-$7.2M-1805.0%	-$377K-124.4%	$1.5M+216.4%	-$1.3M+69.7%	-$4.4M-1032.1%	-$386K-105.0%	$7.7M-69.2%	$25.0M+48.7%	$16.8M+123.3%	$7.5M+12.8%	$6.7M
Net Income	-$885K	-$9.9M-31.6%	-$7.5M-15.0%	-$6.5M+36.5%	-$10.3M+26.5%	-$14.0M+47.8%	-$26.8M-234.8%	-$8.0M+37.1%	-$12.7M-11.1%	-$11.5M-538.1%	-$1.8M-119.1%	$9.4M-74.1%	$36.3M+58.3%	$23.0M+85.5%	$12.4M+24.0%	$10.0M
EPS (Basic)	N/A	-$0.13-30.0%	-$0.10-11.1%	-$0.09+47.1%	-$0.17+34.6%	-$0.26+48.0%	-$0.50-233.3%	-$0.15+40.0%	-$0.25-8.7%	-$0.23-475.0%	-$0.04-121.1%	$0.19-75.3%	$0.77+60.4%	$0.48+242.9%	$0.14+40.0%	$0.10
EPS (Diluted)	-$0.01	-$0.13-30.0%	-$0.10-11.1%	-$0.09+47.1%	-$0.17+34.6%	-$0.26+48.0%	-$0.50-233.3%	-$0.15+40.0%	-$0.25-8.7%	-$0.23-475.0%	-$0.04-121.1%	$0.19-74.3%	$0.74+68.2%	$0.44	$0.13+44.4%	$0.09
Diluted Shares (Avg)	N/A	78M+1.8%	76M+4.4%	73M+20.6%	60M+11.1%	54M+1.8%	53M+2.7%	52M+2.7%	51M+1.3%	50M+1.3%	49M-0.8%	50M+0.9%	49M+3.8%	48M	46M+1.6%	45M

Metric	Q2'2510-Q	Q1'2510-Q	Q4'2410-Q	Q3'2410-Q	Q2'2410-Q	Q1'2410-Q	Q4'2310-K	Q3'2310-Q
Revenue	$37.8M+28.7%	$33.3M+21.7%	$34.8M+6.8%	$31.5M+5.2%	$29.4M+15.2%	$27.3M+6.2%	$32.6M+11.4%	$30.0M+10.2%
SG&A Expenses	$26.8M+9.3%	$25.4M+9.2%	$26.7M+14.6%	$26.0M+13.0%	$24.5M+13.0%	$23.2M+3.4%	$23.3M+4.9%	$23.0M+5.6%
Operating Income	$2.6M+196.3%	$150K+103.8%	-$689K-136.0%	-$2.1M-230.6%	-$2.7M+23.9%	-$3.9M-3.5%	$1.9M+837.3%	-$650K+71.9%
EBITDA	$4.1M+592.3%	$1.6M+163.5%	$711K-78.1%	-$249K-138.3%	-$841K+63.5%	-$2.5M+0.7%	$3.3M+145.2%	$650K+153.5%
Interest Expense	$276K-8.0%	$289K+55.4%	-$99K-112.6%	$313K-26.0%	$300K-14.5%	$186K-55.1%	$786K+118.9%	$423K+52.7%
Income Tax	$360K+2150.0%	$40K+150.0%	-$398K-1692.0%	$15K+103.7%	$16K-23.8%	$16K-23.8%	$25K-68.8%	-$407K-3600.0%
Net Income	$2.1M+169.4%	-$81K+98.0%	-$498K-139.7%	-$2.4M-311.0%	-$3.0M+24.6%	-$4.0M+4.8%	$1.3M+634.0%	-$580K+60.3%
EPS (Basic)	$0.03+175.0%	$0.00+100.0%	-$0.01-150.0%	-$0.03-200.0%	-$0.04+20.0%	-$0.05+16.7%	$0.02	-$0.01+50.0%
EPS (Diluted)	$0.03+175.0%	$0.00+100.0%	-$0.01-150.0%	-$0.03-200.0%	-$0.04+20.0%	-$0.05+16.7%	$0.02	-$0.01+50.0%
Diluted Shares (Avg)	81M+4.9%	78M+1.8%	N/A	78M+1.7%	77M+1.6%	77M+1.9%	N/A	76M+3.3%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses.

PHLT Balance Sheet

PHLT quarterly balance sheet

Metric	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K	FY1010-K
Total Assets	$101.8M+2.8%	$99.0M-16.7%	$118.8M-2.6%	$122.0M-3.4%	$126.2M-9.1%	$138.9M+0.8%	$137.8M-16.2%	$164.4M-11.2%	$185.1M-23.7%	$242.5M-7.7%	$262.8M+2.2%	$257.3M+21.5%	$211.7M+16.2%	$182.3M	N/A
Current Assets	$38.4M-3.6%	$39.8M-30.8%	$57.5M+5.1%	$54.7M+0.3%	$54.5M+47.4%	$37.0M+16.5%	$31.8M-42.8%	$55.5M-22.9%	$72.0M-34.1%	$109.3M-9.6%	$120.9M+6.2%	$113.9M+65.8%	$68.7M+41.2%	$48.6M	N/A
Cash & Equivalents	$9.3M+28.1%	$7.3M-69.0%	$23.4M+34.8%	$17.3M+8.1%	$16.0M+375.6%	$3.4M-38.2%	$5.5M-74.9%	$21.7M-34.1%	$33.0M-53.7%	$71.2M-11.4%	$80.3M-2.0%	$81.9M+116.4%	$37.8M+89.2%	$20.0M+80.6%	$11.1M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Accounts Receivable	$14.2M-19.4%	$17.6M+11.3%	$15.8M-24.1%	$20.8M-10.4%	$23.2M-14.6%	$27.2M+30.1%	$20.9M	N/A	N/A	N/A	N/A	N/A	N/A	$500K	N/A
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$47.4M0.0%	$47.4M0.0%	$47.4M0.0%	$47.4M0.0%	$47.4M-36.3%	$74.4M-8.8%	$81.6M0.0%	$81.6M-1.2%	$82.5M0.0%	$82.5M0.0%	$82.5M+1.2%	$81.6M0.0%	$81.6M0.0%	$81.6M	N/A
Total Liabilities	$25.3M+37.9%	$18.3M-46.7%	$34.3M-13.2%	$39.6M-53.0%	$84.2M-1.2%	$85.2M+40.8%	$60.5M-28.0%	$84.1M-14.9%	$98.8M-33.5%	$148.7M-13.4%	$171.7M-6.2%	$183.0M-2.5%	$187.7M-5.2%	$198.0M	N/A
Current Liabilities	$14.0M+12.9%	$12.4M-12.9%	$14.2M-18.8%	$17.5M-77.3%	$77.2M+297.4%	$19.4M+37.9%	$14.1M-67.3%	$43.1M-16.3%	$51.5M-4.2%	$53.7M-3.7%	$55.8M+22.1%	$45.7M+23.5%	$37.0M+37.3%	$26.9M	N/A
Non-Current Liabilities	$11.3M+90.2%	$5.9M-70.5%	$20.1M-8.7%	$22.1M+213.5%	$7.0M-89.3%	$65.8M+8.7%	$60.5M-28.0%	$84.1M-14.9%	$98.8M-33.5%	$148.7M-13.4%	$171.7M-6.2%	$183.0M-2.5%	$187.7M+34.3%	$139.8M	N/A
Long-Term Debt	N/A	$0-100.0%	$18.2M-4.7%	$19.1M	N/A	$58.6M+42.5%	$41.1M+6.6%	$38.6M-30.1%	$55.2M-41.5%	$94.3M-15.7%	$111.8M-16.1%	$133.3M-3.9%	$138.7M-7.9%	$150.5M	N/A
Total Equity	$76.5M-5.2%	$80.7M-4.5%	$84.5M+2.5%	$82.4M+96.3%	$42.0M-21.7%	$53.6M-30.6%	$77.2M-3.9%	$80.3M-6.9%	$86.2M-8.1%	$93.9M+2.9%	$91.2M+22.8%	$74.2M+208.4%	$24.1M+253.3%	-$15.7M+27.3%	-$21.6M
Retained Earnings	-$75.2M-15.2%	-$65.3M-13.0%	-$57.8M-12.8%	-$51.2M-25.1%	-$41.0M-51.9%	-$27.0M-18000.0%	-$149K-101.9%	$7.9M-61.8%	$20.6M-35.7%	$32.0M-5.3%	$33.8M+38.5%	$24.4M+305.3%	-$11.9M+63.7%	-$32.8M	N/A

Metric	Q2'2510-Q	Q1'2510-Q	Q4'2410-Q	Q3'2410-Q	Q2'2410-Q	Q1'2410-Q	Q4'2310-K	Q3'2310-Q
Total Assets	$111.0M+8.3%	$105.4M+6.2%	$101.8M+2.8%	$101.8M+1.1%	$102.4M+1.8%	$99.2M-4.2%	$99.0M-16.7%	$100.7M-14.9%
Current Assets	$47.5M+24.5%	$42.0M+23.1%	$38.4M-3.6%	$38.3M-8.7%	$38.1M-6.9%	$34.1M-22.1%	$39.8M-30.8%	$42.0M-26.2%
Cash & Equivalents	$9.1M-12.9%	$10.0M+163.5%	$9.3M+28.1%	$7.8M-55.1%	$10.4M-30.4%	$3.8M-69.3%	$7.3M-69.0%	$17.3M-32.4%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Accounts Receivable	$17.7M+26.1%	$14.7M+3.0%	$14.2M-19.4%	$18.0M+27.1%	$14.1M+10.0%	$14.3M-8.7%	$17.6M+11.3%	$14.1M-10.9%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$47.4M0.0%	$47.4M0.0%	$47.4M0.0%	$47.4M0.0%	$47.4M0.0%	$47.4M0.0%	$47.4M0.0%	$47.4M0.0%
Total Liabilities	$28.7M+8.1%	$27.2M+26.1%	$25.3M+37.9%	$26.6M+18.9%	$26.6M+17.2%	$21.6M-4.4%	$18.3M-46.7%	$22.4M-34.9%
Current Liabilities	$18.0M+25.1%	$16.4M+32.3%	$14.0M+12.9%	$14.4M+19.0%	$14.4M+19.2%	$12.4M+8.0%	$12.4M-12.9%	$12.1M-10.3%
Non-Current Liabilities	$10.7M-12.0%	$10.8M+17.9%	$11.3M+90.2%	$12.2M+18.7%	$12.2M+14.9%	$9.2M-17.1%	$5.9M-70.5%	$10.3M-50.7%
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	$0-100.0%	$9.1M-50.7%
Total Equity	$82.2M+8.4%	$78.1M+0.6%	$76.5M-5.2%	$75.2M-3.9%	$75.9M-2.6%	$77.6M-4.2%	$80.7M-4.5%	$78.3M-6.6%
Retained Earnings	-$73.2M-1.2%	-$75.3M-8.6%	-$75.2M-15.2%	-$74.7M-12.2%	-$72.3M-9.6%	-$69.3M-11.8%	-$65.3M-13.0%	-$66.6M-15.7%

Not reported in any period shown, so not listed: Inventory.

PHLT Cash Flow Statement

PHLT quarterly cash flow statement

Metric	TTM	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K	FY1010-K
Operating Cash Flow	$4.8M	$6.2M+60.1%	$3.9M+234.2%	-$2.9M-414.1%	$916K-95.6%	$20.8M+234.9%	-$15.4M-26.9%	-$12.1M-508.5%	$3.0M-83.3%	$17.8M+10.0%	$16.2M-42.0%	$27.9M-54.5%	$61.2M+65.4%	$37.0M+27.7%	$29.0M+59.1%	$18.2M
Depreciation & Amortization	N/A	$6.6M+27.2%	$5.2M+14.7%	$4.5M-12.8%	$5.2M-0.5%	$5.2M-38.9%	$8.5M-16.6%	$10.2M-6.0%	$10.9M-18.6%	$13.4M+1.9%	$13.1M+5.5%	$12.4M+16.8%	$10.7M+12.1%	$9.5M+22.4%	$7.8M+7.7%	$7.2M
Stock-Based Compensation	N/A	$5.9M+49.4%	$3.9M+29.6%	$3.0M+15.0%	$2.6M+1.1%	$2.6M+12.9%	$2.3M-16.0%	$2.8M-26.5%	$3.7M-20.6%	$4.7M-5.9%	$5.0M+35.1%	$3.7M+23.8%	$3.0M+85.5%	$1.6M+1245.0%	$120K-80.9%	$629K
Capital Expenditures	$5.2M	$7.0M+69.2%	$4.1M+15.6%	$3.6M+4.9%	$3.4M-9.9%	$3.8M-21.9%	$4.9M-36.5%	$7.6M+5.3%	$7.3M-7.7%	$7.9M-0.4%	$7.9M-22.2%	$10.1M-18.9%	$12.5M+10.1%	$11.4M+85.8%	$6.1M+24.2%	$4.9M
Free Cash Flow	-$441K	-$832K-194.0%	-$283K+95.6%	-$6.5M-158.5%	-$2.5M-114.7%	$17.0M+183.9%	-$20.3M-2.5%	-$19.8M-361.9%	-$4.3M-143.2%	$9.9M+19.8%	$8.3M-53.3%	$17.7M-63.6%	$48.7M+89.9%	$25.6M+12.1%	$22.9M+72.1%	$13.3M
Investing Cash Flow	-$5.2M	-$7.0M-69.3%	-$4.1M-339.2%	$1.7M+741.1%	-$270K+92.9%	-$3.8M+21.9%	-$4.9M+9.4%	-$5.4M+26.2%	-$7.3M+7.7%	-$7.9M-18.7%	-$6.6M+34.7%	-$10.1M+18.9%	-$12.5M-2.5%	-$12.2M-99.5%	-$6.1M-24.2%	-$4.9M
Financing Cash Flow	-$907K	$2.8M+117.6%	-$15.9M-413.2%	$5.1M+732.4%	$608K+116.4%	-$3.7M-120.6%	$18.0M+1287.7%	$1.3M+110.2%	-$12.7M+68.8%	-$40.6M-117.4%	-$18.7M+3.3%	-$19.3M-316.9%	-$4.6M+33.5%	-$7.0M+50.0%	-$13.9M-25.2%	-$11.1M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0	$0-100.0%	$1.8M	$0	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0	$0-100.0%	$1.2M	$0	N/A

Metric	Q2'2510-Q	Q1'2510-Q	Q4'2410-Q	Q3'2410-Q	Q2'2410-Q	Q1'2410-Q	Q4'2310-K	Q3'2310-Q
Operating Cash Flow	$430K-90.6%	$2.9M+2300.0%	$2.8M+247.5%	-$1.3M-137.7%	$4.6M+3.9%	$121K+105.6%	-$1.9M-171.5%	$3.5M+5.6%
Depreciation & Amortization	$1.5M-21.1%	$1.5M+3.9%	$1.4M-2.0%	$1.9M+46.2%	$1.9M+46.2%	$1.4M+12.1%	$1.4M+18.2%	$1.3M+18.2%
Stock-Based Compensation	$2.1M+61.5%	$1.7M+79.1%	N/A	$1.9M+72.7%	$1.3M+44.4%	$957K+19.9%	N/A	$1.1M+22.2%
Capital Expenditures	$1.3M+51.2%	$1.4M-60.3%	$1.3M+6.7%	$1.2M+100.0%	$858K-40.0%	$3.7M+301.8%	$1.2M-14.4%	$617K+1.3%
Free Cash Flow	-$867K-123.3%	$1.5M+141.2%	$1.5M+149.3%	-$2.5M-188.8%	$3.7M+24.9%	-$3.5M-15.5%	-$3.1M-47.6%	$2.9M+6.6%
Investing Cash Flow	-$1.3M-51.2%	-$1.4M+60.3%	-$1.3M-6.7%	-$1.2M-100.0%	-$858K+40.0%	-$3.7M-303.1%	-$1.2M+14.4%	-$617K-114.3%
Financing Cash Flow	-$38K-101.3%	-$765K-5364.3%	$0+100.0%	-$104K+80.7%	$2.9M+963.2%	-$14K+99.8%	-$7.0M-5485.6%	-$539K-331.2%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

PHLT Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PHLT quarterly financial ratios

Metric	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K	FY1010-K
Operating Margin	-7.7%-2.3pp	-5.4%+0.9pp	-6.3%-5.3pp	-1.1%+7.9pp	-9.0%+4.1pp	-13.1%-11.9pp	-1.1%+4.2pp	-5.4%+0.2pp	-5.6%-9.8pp	4.2%-9.8pp	14.0%-14.6pp	28.5%+2.0pp	26.6%+6.1pp	20.4%-5.3pp	25.7%
Net Margin	-8.1%-1.4pp	-6.6%-0.6pp	-6.0%+2.3pp	-8.3%+0.7pp	-9.0%+8.9pp	-17.8%-12.7pp	-5.1%+4.5pp	-9.6%-1.5pp	-8.1%-7.0pp	-1.1%-5.9pp	4.8%-9.4pp	14.2%+3.3pp	10.9%+3.3pp	7.6%-0.5pp	8.1%
Return on Equity	-12.9%-3.6pp	-9.3%-1.6pp	-7.7%+4.7pp	-12.5%+20.8pp	-33.3%+16.7pp	-50.0%-39.6pp	-10.4%+5.5pp	-15.8%-2.6pp	-13.3%-11.4pp	-1.9%-12.2pp	10.3%-38.6pp	48.9%-46.4pp	95.3%	N/A	N/A
Return on Assets	-9.7%-2.1pp	-7.6%-2.1pp	-5.5%+2.9pp	-8.4%+2.6pp	-11.1%+8.2pp	-19.3%-13.5pp	-5.8%+1.9pp	-7.7%-1.6pp	-6.2%-5.4pp	-0.7%-4.3pp	3.6%-10.6pp	14.1%+3.3pp	10.8%+4.0pp	6.8%	N/A
Current Ratio	2.75-0.5x	3.21-0.8x	4.05+0.9x	3.12+2.4x	0.71-1.2x	1.90-0.4x	2.25+1.0x	1.29-0.1x	1.40-0.6x	2.03-0.1x	2.17-0.3x	2.49+0.6x	1.86+0.1x	1.81	N/A
Debt-to-Equity	0.33+0.3x	0.00-0.2x	0.220.0x	0.23-1.8x	2.01+0.9x	1.09+0.6x	0.53+0.1x	0.48-0.2x	0.64-0.4x	1.00-0.2x	1.23-0.6x	1.80-4.0x	5.76	N/A	N/A
Asset Turnover	1.21+0.1x	1.15+0.2x	0.92-0.1x	1.02-0.2x	1.24+0.2x	1.080.0x	1.13+0.3x	0.800.0x	0.76+0.1x	0.66-0.1x	0.74-0.2x	0.990.0x	0.99+0.1x	0.89	N/A
FCF Margin	-0.7%-0.4pp	-0.3%+5.7pp	-5.9%-3.9pp	-2.0%-12.9pp	10.9%+24.4pp	-13.5%-0.8pp	-12.7%-9.5pp	-3.3%-10.3pp	7.0%+1.8pp	5.2%-3.9pp	9.1%-10.0pp	19.1%+6.9pp	12.2%-1.8pp	14.0%+3.3pp	10.8%

Metric	Q2'2510-Q	Q1'2510-Q	Q4'2410-Q	Q3'2410-Q	Q2'2410-Q	Q1'2410-Q	Q4'2310-K	Q3'2310-Q
Operating Margin	7.0%+16.3pp	0.4%+14.8pp	-2.0%-7.8pp	-6.8%-4.7pp	-9.3%+4.8pp	-14.3%+0.4pp	5.9%+5.2pp	-2.2%+6.3pp
Net Margin	5.5%+15.7pp	-0.2%+14.5pp	-1.4%-5.3pp	-7.6%-5.6pp	-10.2%+5.4pp	-14.7%+1.7pp	3.9%+4.7pp	-1.9%+3.4pp
Return on Equity	2.5%+6.5pp	-0.1%+5.1pp	-0.7%-2.2pp	-3.2%-2.4pp	-4.0%+1.1pp	-5.2%0.0pp	1.6%+1.8pp	-0.7%+1.0pp
Return on Assets	1.9%+4.8pp	-0.1%+4.0pp	-0.5%-1.8pp	-2.3%-1.8pp	-2.9%+1.0pp	-4.0%0.0pp	1.3%+1.5pp	-0.6%+0.7pp
Current Ratio	2.640.0x	2.56-0.2x	2.75-0.5x	2.67-0.8x	2.65-0.7x	2.75-1.1x	3.21-0.8x	3.48-0.7x
Debt-to-Equity	0.350.0x	0.35+0.1x	0.33+0.3x	0.35+0.2x	0.35+0.2x	0.28+0.2x	0.00-0.2x	0.12-0.1x
Asset Turnover	0.34+0.1x	0.320.0x	0.340.0x	0.310.0x	0.290.0x	0.280.0x	0.33+0.1x	0.30+0.1x
FCF Margin	-2.3%-15.0pp	4.4%+17.3pp	4.4%+13.8pp	-8.1%-17.6pp	12.7%+1.0pp	-12.9%-1.0pp	-9.4%-2.3pp	9.6%-0.3pp

Not reported in any period shown, so not listed: Gross Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Performant Healthcare, Inc. PHLT	FY2024	$123.0M	-$9.9M	-8.1%	$612.2M	56/100
Weave Communications, Inc. WEAV	FY2025	$239.0M	-$28.1M	-11.7%	$593.7M	43/100
HealthStream Inc HSTM	FY2025	$304.1M	$18.3M	6.0%	$1.0B	55/100
Definitive Healthcare Corp. DH	FY2025	$241.5M	-$138.9M	-57.5%	$104.6M	40/100
NRC Health NRC	FY2025	$137.4M	$11.6M	8.4%	$451.5M	50/100
Talkspace, Inc. TALK	FY2025	$228.9M	$7.8M	3.4%	$870.6M	55/100

Where Performant Healthcare, Inc. Ranks

Frequently Asked Questions

What is Performant Healthcare, Inc.'s annual revenue?

Performant Healthcare, Inc. (PHLT) reported $123.0M in total revenue for fiscal year 2024. This represents a 8.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Performant Healthcare, Inc.'s revenue growing?

Performant Healthcare, Inc. (PHLT) revenue grew by 8.1% year-over-year, from $113.7M to $123.0M in fiscal year 2024.

Is Performant Healthcare, Inc. profitable?

No, Performant Healthcare, Inc. (PHLT) reported a net income of -$9.9M in fiscal year 2024, with a net profit margin of -8.1%.

What is Performant Healthcare, Inc.'s EBITDA?

Performant Healthcare, Inc. (PHLT) had EBITDA of -$2.9M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

What is Performant Healthcare, Inc.'s operating margin?

Performant Healthcare, Inc. (PHLT) had an operating margin of -7.7% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.

What is Performant Healthcare, Inc.'s net profit margin?

Performant Healthcare, Inc. (PHLT) had a net profit margin of -8.1% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

What is Performant Healthcare, Inc.'s return on equity (ROE)?

Performant Healthcare, Inc. (PHLT) has a return on equity of -12.9% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.

What is Performant Healthcare, Inc.'s free cash flow?

Performant Healthcare, Inc. (PHLT) recorded an outflow of $832K in free cash flow during fiscal year 2024. This represents a -194.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Performant Healthcare, Inc.'s operating cash flow?

Performant Healthcare, Inc. (PHLT) generated $6.2M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

What are Performant Healthcare, Inc.'s total assets?

Performant Healthcare, Inc. (PHLT) had $101.8M in total assets as of fiscal year 2024, including both current and long-term assets.

What are Performant Healthcare, Inc.'s capital expenditures?

Performant Healthcare, Inc. (PHLT) invested $7.0M in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.

How many shares does Performant Healthcare, Inc. have outstanding?

Performant Healthcare, Inc. (PHLT) had 78M shares outstanding as of fiscal year 2024.

What is Performant Healthcare, Inc.'s current ratio?

Performant Healthcare, Inc. (PHLT) had a current ratio of 2.75 as of fiscal year 2024, which is generally considered healthy.

What is Performant Healthcare, Inc.'s debt-to-equity ratio?

Performant Healthcare, Inc. (PHLT) had a debt-to-equity ratio of 0.33 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Performant Healthcare, Inc.'s return on assets (ROA)?

Performant Healthcare, Inc. (PHLT) had a return on assets of -9.7% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

What is Performant Healthcare, Inc.'s Altman Z-Score?

Performant Healthcare, Inc. (PHLT) has an Altman Z-Score of 14.69, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Performant Healthcare, Inc.'s Piotroski F-Score?

Performant Healthcare, Inc. (PHLT) has a Piotroski F-Score of 3 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Performant Healthcare, Inc.'s earnings high quality?

Performant Healthcare, Inc. (PHLT) reported a net loss of $9.9M while generating $6.2M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Performant Healthcare, Inc. cover its interest payments?

Performant Healthcare, Inc. (PHLT) reported an operating loss of $9.5M against $700K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Performant Healthcare, Inc.?

Performant Healthcare, Inc. (PHLT) scores 56 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.